Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Illumina's SNP Chip Users (US)(?)

Council Members in this Study Group: 34

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Ken Powell, President, Genesis Business DevelopmentKen Powell
President
Genesis Business Development

Ken Powell is the President of Genesis Business Development, a global healthcare consultancy. Mr. Powell has experience in the identification, acquisition, and commercialization of intellectual property, new businesses, and products in the medical device and clinical diagnostics market segments worldwide....

Gregory Khitrov, PhD, Director of Personalized Medicine Program, MOUNT SINAI SCHOOL OF MEDICINE Gregory Khitrov, PhD
Director of Personalized Medicine Program
MOUNT SINAI SCHOOL OF MEDICINE

Greg Khitrov, PhD, is the Director of Life Sciences Technology Center at the Institute for Personalized Medicine, Director of Biobank and an Assistant Professor of Medicine at the Mount Sinai School of Medicine in New York. He has expertise in molecular biology; proteomics; and laboratory automation...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
New blood-based test for colorectal cancer | 07-28-2008
Author: Ken Powell, President, Genesis Business Development

A non-invasive, DNA-based screening test for colon cancer could significantly increase the 90MM US adults over 50 that should participate in colorectal cancer screening.  Colon cancer is responsible for approximately 57,000 deaths in the US each year and account for 9% of all cancer deaths. ...

New Developments in Sepsis Diagnostics | 07-24-2008
Analysis of: SIRS-Lab Pre-Announces Biomarker Based Sepsis Test | www.medcompare.com
Author: Ken Powell, President, Genesis Business Development

Severe sepsis is a major cause of death in the US.  Annual mortality rates of over 215,000 patients exceed those for acute myocardial infarction and leading cancers.  A sensitive and specific marker could relieve the huge medical and financial burden created by the 750,000 cases of sepsis...

Infectious Diseases | 07-15-2008
Author: Ken Powell, President, Genesis Business Development

BD GeneOhm's recent CE Mark for its molecular diagnostic test for the rapid diagnosis of Clostridium difficile infection will likely intensify the competition between BD and Cepheid.  Both companies market tests for the $1 billion dollar Methicillin-Resistant Staphylococcus Aureus (MRSA)&...

Novel Test for Appendicitis | 07-15-2008
Author: Ken Powell, President, Genesis Business Development

A new test form AspenBio could revolutionalize the diagnosis of appendicitis.  Over 6 million patients present to Emergency Departments each year with abdominal pain, resulting in approximately 700,000 appendectomies.  Over $5 billion is spent each year in the US on CT scans, the currently...

Competitive Bidding Demo Repealed by House of Representatives | 07-11-2008
Author: Ken Powell, President, Genesis Business Development

The House of Representatives repealed the Centers for Medicare and Medicaid Services (CMS) authority to conduct a competitive bidding demonstration program for laboratory services.  Senate action is now required.

View All GLG News by members of this Study Group

GLG InstituteSM Seminars with this Study Group's Leading Experts(?)

 

Recent Seminars

GLGi: Genotyping Technologies
New York, 04-26-2007

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Academic Institution*
  • Pharmaceuticals Manufacturer
  • Research Foundation

Most Common Job Types:

  • Director
  • Research Scientist
  • Physician - Attending Physician
  • Professor
  • Physician - Department Chair
  • Researcher
  • Physician - Director

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics